Acquired resistance to imatinib mesylate: selection for pre-existing mutant cells
- PMID: 12150157
- DOI: 10.1182/blood-2002-05-1578
Acquired resistance to imatinib mesylate: selection for pre-existing mutant cells
Comment on
-
High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance.Blood. 2002 May 1;99(9):3472-5. doi: 10.1182/blood.v99.9.3472. Blood. 2002. PMID: 11964322
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources

